LENVATINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY (R/R) SOLID TUMORS: RESULTS FROM THE SINGLE-ARM, PHASE 2 HOPSKIP STUDY

被引：0

作者：

Kang, Hyoung Jin ^{[1
]}

Abbou, Samuel ^{[2
]}

Mudry, Peter ^{[3
]}

Nicholls, Wayne ^{[4
]}

Kabickova, Edita ^{[5
,6
]}

Andre, Nicolas ^{[7
]}

Koh, Kyung-Nam ^{[8
]}

Casanova, Michela ^{[9
]}

Cefalo, Maria Giuseppina ^{[10
]}

Lombardi, Mercedes Garcia ^{[11
]}

Corradini, Nadege ^{[12
,13
]}

Naidu, Gita ^{[14
]}

Mckenzie, Jodi ^{[15
]}

Song, Yue ^{[16
]}

Singh, Rohini ^{[16
]}

Bidadi, Behzad ^{[16
]}

San Simon, Alba Rubio ^{[17
]}

机构：

[1] Seoul Natl Univ, Coll Med, Canc Res Inst, Childrens Hosp,Dept Pediat, Seoul, South Korea

[2] Paris Saclay Univ, INSERM, U1015, Children & Adolescent Oncol Dept, Villejuif, France

[3] Univ Hosp Brno, Dept Pediat Oncol, Brno, Czech Republic

[4] Childrens Hlth Queensland Hosp & Hlth Serv, Paediat Oncol, South Brisbane, Australia

[5] Charles Univ Prague, Prague, Czech Republic

[6] Univ Hosp Motol, Dept Pediat Hematol & Oncol, Prague, Czech Republic

[7] Hop Enfants La Timone, Smartc, Marseille, France

[8] Asan Med Ctr, Pediat, Seoul, South Korea

[9] Fdn IRCCS Ist Nazl Tumori, Pediat Oncol Unit, Milan, Italy

[10] Bambino Gesu Pediat Hosp, Oncohematol Cell & Gene Therapy, Rome, Italy

[11] Hosp Ninos Dr Ricardo Gutierrez, Oncol, Buenos Aires, DF, Argentina

[12] Ctr Leon Berard, Lyon, France

[13] Inst Hematol & Oncol Pediat, Oncol & Hematol, Lyon, France

[14] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Global Pediat Med, Johannesburg, South Africa

[15] Eisai Inc, Med Oncol, Nutley, NJ USA

[16] Merck & Co Inc, Med Oncol, Rahway, NJ USA

[17] Hosp Infantil Univ Nino Jesus, Dept Pediat Hematooncol, Madrid, Spain

来源：

PEDIATRIC BLOOD & CANCER | 2023年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O211

引用

页码：S119 / S119

页数：1

共 50 条

[1] Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)
Gaspar, N.
Campbell-Hewson, Q.
Gallego Melcon, S.
Locatelli, F.
Venkatramani, R.
Hecker-Nolting, S.
Gambart, M.
Bautista, F.
Thebaud, E.
Aerts, I.
Morland, B.
Rossig, C.
Canete Nieto, A.
Longhi, A.
Lervat, C.
Entz-Werle, N.
Strauss, S. J.
Marec-Berard, P.
Okpara, C. E.
He, C.
Dutta, L.
Casanova, M.
ESMO OPEN, 2021, 6 (05)
[2] RESULTS OF A PHASE 2, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY OF LENALIDOMIDE IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
O'Brien, Maureen
Alonzo, Todd
Cooper, Todd
Levine, John
Brown, Patrick
Slone, Tamra
Benettaib, Bouchra
Biserna, Noha
Poon, Jennifer
Quan, Jackie
Simcock, Mathew
Weiss, Daniel
Zimmerman, Linda
Kolb, Edward
PEDIATRIC BLOOD & CANCER, 2018, 65
[3] Single-agent dose-finding cohort of a phase 1/2 study of lenvatinib (LEN) in children and adolescents with refractory or relapsed solid tumors.
Gaspar, Nathalie
Melcon, Maria Soledad Gallego
Venkatramani, Rajkumar
Bielack, Stefan S.
Casanova, Michela
Locatelli, Franco
Thebaud, Estelle
Rigaud, Charlotte
Abbou, Samuel
Gambart, Marion
Morland, Bruce
Aerts, Isabelle
Kraljevic, Silvija
Li, Di
Maniar, Hina
Hayato, Seiichi
Dutcus, Corina E.
Hewson, Quentin Campbell
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[4] A phase II study of pazopanib in children, adolescents, and young adults with refractory solid tumors.
Lee, Alice
Bender, Julia Glade
Weigel, Brenda
Fox, Elizabeth
Huff, Anne C.
Tada, Hiroomi
Blaney, Susan M.
Langmuir, Peter
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] PENPULIMAB FOR RELAPSED/REFRACTORY (R/R) CLASSICAL HODGKIN'S LYMPHOMA (CHL): EXTENDED FOLLOW-UP OF THE MULTICENTER, SINGLE-ARM, PHASE 2 STUDY
Song, Yuqin
Zhou, Keshu
Jin, Chuan
Qian, Zhengzi
Hou, Ming
Fan, Lei
Li, Fei
Ding, Kaiyang
Zhou, Hui
Li, Xiaoling
Chen, Bing
Sun, Xiuhua
Song, Xianmin
Jiang, Ming
Zhang, Qingyuan
Liu, Lihong
Yu, Guohua
Hu, Yu
Zhao, Zheng
Liu, Ligen
Xue, Hongwei
Luo, Jun
He, Bai
Yao, Zhifang
Xu, Fenghua
Zhao, Min
Li, Baiyong
Xia, Yu
Zhu, Jun
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A598 - A598
[6] Phase 1 Trial of Temsirolimus in Combination with Irinotecan and Temozolomide in Children, Adolescents and Young Adults with Relapsed or Refractory Solid Tumors: A Children's Oncology Group Study
Bagatell, Rochelle
Norris, Robin
Ingle, Ashish M.
Ahern, Charlotte
Voss, Stephan
Fox, Elizabeth
Little, Anthony R.
Weigel, Brenda J.
Adamson, Peter C.
Blaney, Susan
PEDIATRIC BLOOD & CANCER, 2014, 61 (05) : 833 - 839
[7] Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial
Davis, Kara L.
Fox, Elizabeth
Merchant, Melinda S.
Reid, Joel M.
Kudgus, Rachel A.
Liu, Xiaowei
Minard, Charles G.
Voss, Stephan
Berg, Stacey L.
Weigel, Brenda J.
Mackall, Crystal L.
LANCET ONCOLOGY, 2020, 21 (04): : 541 - 550
[8] Phase 2 Trial of Cixutumumab in Children, Adolescents, and Young Adults With Refractory Solid Tumors: A Report From the Children's Oncology Group
Weigel, Brenda
Malempati, Suman
Reid, Joel M.
Voss, Stephan D.
Cho, Steven Y.
Chen, Helen X.
Krailo, Mark
Villaluna, Doojduen
Adamson, Peter C.
Blaney, Susan M.
PEDIATRIC BLOOD & CANCER, 2014, 61 (03) : 452 - 456
[9] Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors
Vo, Kieuhoa T.
Karski, Erin E.
Nasholm, Nicole M.
Allen, Shelly
Hollinger, Fabienne
Gustafson, W. Clay
Long-Boyle, Janel R.
Shiboski, Stephen
Matthay, Katherine K.
DuBois, Steven G.
ONCOTARGET, 2017, 8 (14) : 23851 - 23861
[10] Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias
Shah, Nirali N.
Merchant, Melinda S.
Cole, Diane E.
Jayaprakash, Nalini
Bernstein, Donna
Delbrook, Cindy
Richards, Kelly
Widemann, Brigitte C.
Wayne, Alan S.
PEDIATRIC BLOOD & CANCER, 2016, 63 (06) : 997 - 1005

← 1 2 3 4 5 →